Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares trading hands.
Resverlogix Trading Down 9.1 %
The firm has a 50 day moving average of C$0.06 and a 200-day moving average of C$0.06. The company has a market cap of C$13.85 million, a P/E ratio of -1.00 and a beta of 0.71.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is a Dividend King?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- 3 Warren Buffett Stocks to Buy Now
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
